Home
Fairmount Funds Management reported a 19.5% stake in Oruka Therapeutics ORKA · 14,572,917 sh · amendment
Trade details
- Type
- 5% stake report
- Report
- 13D · amendment
- Stake
- 19.5%
- Last report
- 19.99% · filed 26/05/04
- Shares held
- 14,572,917 sh
- Class
- Common Stock, $0.001 par value per share
- Event date
- 26/07/01
- Filed
- 26/07/01
19.5% stake · −0.5pp from the last report
- Stake
- 19.5%
- Last report
- 19.99%
- Since last report
- −0.5pp
Oruka Therapeutics trades, last 26 weeks
What else happened in Oruka Therapeutics around then
Filed or reported within 30 days of the trade day · 06/01~07/31Fairmount Funds Management's other 5% stake reports
- Fairmount Funds Management
5% stakeKorsana Biosciences
5% stakeKorsana Biosciences
KRSA
19.99% stake
9,106,420 sh
19.99% stake
Filed 09/11
- Fairmount Funds Management
5% stakeCrescent Biopharma
5% stakeCrescent Biopharma
CBIO
16.52% stake
6,602,408 sh
16.52% stake
Filed 07/20
- Fairmount Funds Management
5% stakeSpyre Therapeutics
5% stakeSpyre Therapeutics
SYRE
9.99% stake
9,667,201 sh
9.99% stake
Filed 06/23
- Fairmount Funds Management
5% stakeJade Biosciences
5% stakeJade Biosciences
JBIO
19.99% stake
14,069,494 sh
19.99% stake
Filed 06/09
- Fairmount Funds Management
5% stakeEnliven Therapeutics
5% stakeEnliven Therapeutics
ELVN
3.1% stake
1,855,644 sh
3.1% stake
Filed 05/15
